EXAGEN INC. Cash Flow Statement
XGN|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
EXAGEN INC. used $13M in operating cash flow and negative free cash flow of $14M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$15.1M | -$23.7M | -$47.4M | -$26.9M | -$16.7M | -$12.0M | -$8.0M |
| Depreciation & Amortization | $1.7M | $2.2M | $1.6M | $900.0K | $500.0K | $600.0K | $600.0K |
| Operating Cash Flow | -$13.3M | -$14.5M | -$32.1M | -$20.3M | -$14.1M | -$9.7M | -$9.3M |
| Capital Expenditures | $515.0K | $828.0K | $4.3M | $2.4M | $455.0K | $403.0K | $199.0K |
| Free Cash Flow | -$13.8M | -$15.3M | -$36.5M | -$22.6M | -$14.5M | -$10.1M | -$9.5M |
| FCF Margin | -24.8% | -29.1% | -80.0% | -46.9% | -34.6% | -25.0% | -29.3% |